Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hakan Harputluoglu

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
World Journal of Urology|January 22, 2015
Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical OncologyAhmet Bilici, Turkan Ozturk, Esma Turkmen, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Japanese Journal of Clinical Oncology|January 25, 2024
Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre studyOmer Fatih Olmez, Ahmet Bilici, Ozlem Er, et al.
Cancers|November 27, 2024
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and OutcomesMehmet Fatih Ozbay, Hakan Harputluoglu, Mustafa Karaca, et al.
Frontiers in Pharmacology|January 5, 2026
Multilocus inherited neoplasia allele syndrome (MINAS) in a Turkish cohort: molecular insights and clinical relevance for precision oncologyTaha Bahsi, Serhat Seyhan, Kaan Helvaci, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 17, 2015
Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction CancersMeltem Baykara, Mustafa Benekli, Ozgur Ekinci, et al.
Acta Oncologica (Stockholm, Sweden)|April 21, 2023
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH studyAhmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2015
Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish StudyHuseyin Abali, Ismail Celik, Burcak Karaca, et al.
JAMA Network Open|May 23, 2023
Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern TurkeyTezer Kutluk, Berksoy Sahin, Meral Kirazli, et al.
Molecular and Clinical Oncology|April 29, 2025
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective studyAlpaslan Ozgun, Fatma Nihan Akkoc Mustafayev, Izzet Dogan, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
World Journal of Urology|January 22, 2015
Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical OncologyAhmet Bilici, Turkan Ozturk, Esma Turkmen, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Japanese Journal of Clinical Oncology|January 25, 2024
Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre studyOmer Fatih Olmez, Ahmet Bilici, Ozlem Er, et al.
Cancers|November 27, 2024
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and OutcomesMehmet Fatih Ozbay, Hakan Harputluoglu, Mustafa Karaca, et al.
Frontiers in Pharmacology|January 5, 2026
Multilocus inherited neoplasia allele syndrome (MINAS) in a Turkish cohort: molecular insights and clinical relevance for precision oncologyTaha Bahsi, Serhat Seyhan, Kaan Helvaci, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 17, 2015
Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction CancersMeltem Baykara, Mustafa Benekli, Ozgur Ekinci, et al.
Acta Oncologica (Stockholm, Sweden)|April 21, 2023
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH studyAhmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2015
Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish StudyHuseyin Abali, Ismail Celik, Burcak Karaca, et al.
JAMA Network Open|May 23, 2023
Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern TurkeyTezer Kutluk, Berksoy Sahin, Meral Kirazli, et al.
Molecular and Clinical Oncology|April 29, 2025
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective studyAlpaslan Ozgun, Fatma Nihan Akkoc Mustafayev, Izzet Dogan, et al.
Pageof 4